Cargando…

Role of Adenosine A(2A) Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease

In the last few years, accumulating evidence has shown the existence of an important cross-talk between adenosine A(2A) receptors (A(2A)Rs) and brain-derived neurotrophic factor (BDNF). Not only are A(2A)Rs involved in the mechanism of transactivation of BDNF receptor TrkB, they also modulate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tebano, Maria Teresa, Martire, Alberto, Chiodi, Valentina, Ferrante, Antonella, Popoli, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763899/ https://www.ncbi.nlm.nih.gov/pubmed/20842321 http://dx.doi.org/10.1100/tsw.2010.164

Ejemplares similares

Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease
por: Potenza, R. L., et al.
Publicado: (2007)

Adenosine A(2A) receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice
por: Ferrante, Antonella, et al.
Publicado: (2021)

Is the functional interaction between adenosine A(2A) receptors and metabotropic glutamate 5 receptors a general mechanism in the brain? Differences and similarities between the striatum and the hippocampus
por: Tebano, M. T., et al.
Publicado: (2006)

P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease
por: Martire, Alberto, et al.
Publicado: (2021)

Adenosine A(2A) receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes
por: De Nuccio, Chiara, et al.
Publicado: (2019)

Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
por: Bernardo, Antonietta, et al.
Publicado: (2021)

Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A(2A) Receptor-Mediated Effects in the Central Nervous System
por: Domenici, Maria Rosaria, et al.
Publicado: (2021)

Functional Interaction between Adenosine A(2A) and mGlu(5) Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu(5)R Binding in Mouse Hippocampus and Neuroblastoma Cell Line
por: Mallozzi, Cinzia, et al.
Publicado: (2023)

BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
por: Kowiański, Przemysław, et al.
Publicado: (2017)

A Role for Oxidized DNA Precursors in Huntington's Disease–Like Striatal Neurodegeneration
por: De Luca, Gabriele, et al.
Publicado: (2008)

The Utility of BDNF Detection in Assessing Severity of Huntington’s Disease
por: Plinta, Klaudia, et al.
Publicado: (2021)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

The Pathophysiology and Pharmacological Treatment of Huntington Disease
por: Pidgeon, Connie, et al.
Publicado: (2013)

Molecular Pathophysiological Mechanisms in Huntington’s Disease
por: Jurcau, Anamaria
Publicado: (2022)

Fmr1-KO mice failure to detect object novelty associates with a post-test decrease of structural and synaptic plasticity upstream of the hippocampus
por: Borreca, Antonella, et al.
Publicado: (2023)

Corticostriatal synaptic adaptations in Huntington’s disease
por: Plotkin, Joshua L., et al.
Publicado: (2015)

Mechanisms That Modulate and Diversify BDNF Functions: Implications for Hippocampal Synaptic Plasticity
por: De Vincenti, Ana Paula, et al.
Publicado: (2019)

A subthreshold synaptic mechanism regulating BDNF expression and resting synaptic strength
por: Horvath, Patricia M., et al.
Publicado: (2021)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease
por: Mai, Maren, et al.
Publicado: (2006)

Localization of BDNF mRNA with the Huntington's disease protein in rat brain
por: Ma, Bin, et al.
Publicado: (2010)

Functional analysis of brain derived neurotrophic factor (BDNF) in Huntington’s disease
por: Zhou, Zhike, et al.
Publicado: (2021)

Oroxylin A Induces BDNF Expression on Cortical Neurons through Adenosine A2(A) Receptor Stimulation: A Possible Role in Neuroprotection
por: Jeon, Se Jin, et al.
Publicado: (2012)

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review
por: Bakels, Hannah S., et al.
Publicado: (2021)

How Are Adenosine and Adenosine A(2A) Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
por: Mori, Akihisa, et al.
Publicado: (2021)

Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington’s Disease
por: Yu, Chenglong, et al.
Publicado: (2018)

Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington’s Disease
por: Trovato, Bruno, et al.
Publicado: (2022)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease
por: Pineda, Jose R, et al.
Publicado: (2009)

Synaptic plasticity in schizophrenia pathophysiology
por: Zhang, Kexuan, et al.
Publicado: (2022)

Synaptic plasticity in schizophrenia pathophysiology
por: Zhang, Kexuan, et al.
Publicado: (2023)

Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway
por: Barry, Joshua, et al.
Publicado: (2022)

The requirement of BDNF for hippocampal synaptic plasticity is experience‐dependent
por: Aarse, Janna, et al.
Publicado: (2016)

Adenosine Receptor Heteromers and their Integrative Role in Striatal Function
por: Ferré, Sergi, et al.
Publicado: (2007)

Expression and Dendritic Trafficking of BDNF-6 Splice Variant are Impaired in Knock-In Mice Carrying Human BDNF Val66Met Polymorphism
por: Mallei, Alessandra, et al.
Publicado: (2015)

Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells
por: Donnici, Lorena, et al.
Publicado: (2008)

Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice
por: Xue, Ziyi, et al.
Publicado: (2022)

Influence of BDNF Genetic Polymorphisms in the Pathophysiology of Aging-related Diseases
por: Urbina-Varela, Rodrigo, et al.
Publicado: (2020)

Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology
por: Rocha, Natalia P., et al.
Publicado: (2021)

Regulation of thalamocortical axon branching by BDNF and synaptic vesicle cycling
por: Granseth, Björn, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ubegvj4u1fc2ng4jd2a8uhhu9g